Higher-dose RT results in inferior survival in patients with stage III lung cancer

In a randomized phase III clinical trial conducted by the Radiation Therapy Oncology Group, high-dose, compared with standard-dose, radiotherapy with concurrent chemotherapy did not improve overall survival of patients with stage III non-small-cell lung cancer.

Fuente : http://www.eurekalert.org/pub_releases/2013-05/aco…


Hacer un comentario